Celerus raises $10M in Series C

Carpinteria, CA-based Celerus Diagnostics has raised $10 million in Series C, according to a regulatory filing. The company didn't disclose the parties involved or other details about the transaction. Celerus, which was founded in 2004, develops products that enhance the diagnostic capabilities of anatomic pathology laboratories, the company says on its website. The Celerus Wave system, which was launched in 2007, allows for immunohistochemistry test results in just 15 minutes on frozen sections or pretreated paraffin sections. Used by breast and MOHs surgeons, the system provides important tissue information during surgery, eliminating the 24 to 48 hour wait for pathology test results and the need to return for additional surgery. SEC filing | More

Suggested Articles

Medtronic has moved to acquire Avenu Medical, developers of a minimally invasive method of building the blood vessel access ports.

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.